Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
71 hedge funds and large institutions have $394M invested in Axonics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 7 reducing their positions, and 4 closing their positions.
550% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 4
329% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 7
161% more capital inflows, than outflows
Capital inflows: $63.6M | Capital outflows: $24.3M
39% more funds holding
Funds holding: 51 → 71 (+20)
4.36% more ownership
Funds ownership: 29.71% → 34.08% (+4.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$15.7M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$6.04M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$5.89M |
| 4 |
State Street
Boston,
Massachusetts
|
+$5.72M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$11.3M |
| 2 |
Millennium Management
New York
|
-$8.64M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$1.47M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$645K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$587K |
AXNX Hedge Fund Activity: Q2 2019 in Review
71 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q2 2019, worth a combined $394M — up 99% from $198M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new AXNX positions and 4 closed out — a net gain of 22 holders — while 30 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock, adding an estimated $15.7M. The largest seller was Perceptive Advisors, cutting an estimated $11.3M.
- 71 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q2 2019, up from 51 in Q1 2019.
- Funds reported $394M of Axonics, Inc. Common Stock stock for Q2 2019, up 99% quarter-over-quarter.
- 26 funds opened new Axonics, Inc. Common Stock positions in Q2 2019 and 4 closed out, a net change of +22 holders.
- The largest Axonics, Inc. Common Stock buyer in Q2 2019 was BlackRock, an estimated $15.7M added.
- The largest Axonics, Inc. Common Stock seller in Q2 2019 was Perceptive Advisors, an estimated $11.3M sold.
Based on aggregated 13F filings for Q2 2019.